Cathie's Ark Logo
Exact Sciences Corp. Logo

Combined Holdings of Exact Sciences Corp. (EXAS) - Updated Daily

Liquid BiopsyGenomicsGenetic Testing

Key Statistics

⚖️Weighting🧢Market Cap
🏋️‍♀️Weight Rank Across All Funds🌏Country
7🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$94.56 - ARKG$106.19 - ARKK
exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit

Other ETFs That Hold EXAS

ARKGARK Genomic Revolution ETF11.77%
ARKKARK Innovation ETF6.43%
XBISPDR® S&P Biotech ETF1.49%
AGNGGlobal X Aging Population ETF0.85%
LABUS&P Biotech Bull 3X Shares ETF0.209%

Research Notes and Commentary for EXAS

No Research Notes Found for EXAS